Last reviewed · How we verify
NCT06286891
Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients
trial in Chronic Thromboembolic Pulmonary Hypertension in 50 participants. Currently enrolling.
1 September 2025
Quick facts
| Lead sponsor | University of Sao Paulo General Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 29 February 2024 |
| Primary completion | 1 September 2025 |
| Estimated completion | 30 September 2026 |
| Sites | 1 location across Brazil |
Conditions studied
- Chronic Thromboembolic Pulmonary Hypertension — all drugs for Chronic Thromboembolic Pulmonary Hypertension →
- Physical Disability — all drugs for Physical Disability →
- Fragility — all drugs for Fragility →
Sponsor
University of Sao Paulo General Hospital
Who can join
18 and older, any sex, with Chronic Thromboembolic Pulmonary Hypertension or Physical Disability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational and prospective study is to investigate changes in physical performance, lung function, respiratory and peripheral muscle strength in patients during the postoperative period following pulmonary endarterectomy (PET).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06286891
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Thromboembolic Pulmonary Hypertension
Currently open trials in the same condition.
- NCT07272798 — Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension · recruiting
- NCT07254078 — Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTension · recruiting
- NCT06922240 — Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART) · Phase 3 · recruiting
- NCT06081881 — Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism · recruiting
- NCT06715280 — Switching of Sildenafil to Riociguat in CTEPH Patients · Phase 4 · recruiting
Other University of Sao Paulo General Hospital trials
Trials by the same sponsor.
- NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07478094 — Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost · not yet recruiting
- NCT07341386 — Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07242092 — Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs · Phase 4 · not yet recruiting
- NCT07484152 — Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06286891 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo General Hospital
- Last refreshed: 28 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06286891.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing